M&T Bank Corp Catalent, Inc. Transaction History

M&T Bank Corp

$30.1 Billion
Q3 2024

A detailed history of M&T Bank Corp transactions in Catalent, Inc. stock. As of the latest transaction made, M&T Bank Corp holds 10,249 shares of CTLT stock, worth $650,606. This represents 0.0% of its overall portfolio holdings.

Number of Shares

10,249

Previous 10,249 -0.0%

Holding current value

$650,606

Previous $620,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	BUY	$56.16 - $60.96 $3,594 - $3,901	64 Added 0.63%	10,249 $620,000
Q2 2024 Jul 31, 2024	SELL	$53.58 - $57.02 $29,469 - $31,361	-550 Reduced 5.12%	10,185 $572,000
Q1 2024 May 07, 2024	SELL	$42.56 - $59.82 $3,021 - $4,247	-71 Reduced 0.66%	10,735 $605,000
Q4 2023 Feb 06, 2024	SELL	$32.18 - $46.57 $93,675 - $135,565	-2,911 Reduced 21.22%	10,806 $485,000
Q3 2023 Nov 02, 2023	SELL	$44.2 - $50.2 $20,287 - $23,041	-459 Reduced 3.24%	13,717 $624,000
Q2 2023 Aug 09, 2023	SELL	$31.86 - $67.26 $150,952 - $318,677	-4,738 Reduced 25.05%	14,176 $614,000
Q1 2023 May 11, 2023	BUY	$45.44 - $74.26 $78,702 - $128,618	1,732 Added 10.08%	18,914 $1.24 Million
Q4 2022 Feb 13, 2023	BUY	$41.39 - $81.0 $95,610 - $187,110	2,310 Added 15.53%	17,182 $773,000
Q4 2022 Feb 13, 2023	SELL	$41.39 - $81.0 $74,626 - $146,043	-1,803 Reduced 10.81%	14,872 $669,000
Q3 2022 Nov 14, 2022	SELL	$72.36 - $113.1 $206,153 - $322,221	-2,849 Reduced 14.59%	16,675 $1.21 Million
Q2 2022 Aug 05, 2022	BUY	$87.2 - $114.05 $1.13 Million - $1.48 Million	13,016 Added 200.0%	19,524 $715,000
Q1 2022 May 09, 2022	BUY	$94.19 - $124.49 $162,666 - $214,994	1,727 Added 36.12%	6,508 $722,000
Q4 2021 Feb 07, 2022	SELL	$119.57 - $139.07 $7,293 - $8,483	-61 Reduced 1.26%	4,781 $612,000
Q3 2021 Oct 28, 2021	SELL	$109.17 - $142.35 $21,288 - $27,758	-195 Reduced 3.87%	4,842 $645,000
Q2 2021 Aug 13, 2021	BUY	$100.34 - $115.69 $17,860 - $20,592	178 Added 3.66%	5,037 $546,000
Q1 2021 May 06, 2021	SELL	$101.51 - $125.27 $53,698 - $66,267	-529 Reduced 9.82%	4,859 $512,000
Q4 2020 Feb 12, 2021	BUY	$85.88 - $105.36 $49,466 - $60,687	576 Added 11.97%	5,388 $560,000
Q3 2020 Nov 06, 2020	BUY	$72.74 - $92.5 $44,371 - $56,425	610 Added 14.52%	4,812 $412,000
Q2 2020 Jul 29, 2020	SELL	$48.02 - $79.04 $1,440 - $2,371	-30 Reduced 0.71%	4,202 $308,000
Q1 2020 May 14, 2020	SELL	$36.95 - $62.95 $56,274 - $95,872	-1,523 Reduced 26.46%	4,232 $220,000
Q4 2019 Feb 07, 2020	SELL	$47.06 - $56.64 $8,329 - $10,025	-177 Reduced 2.98%	5,755 $324,000
Q3 2019 Nov 12, 2019	SELL	$47.45 - $58.05 $6,880 - $8,417	-145 Reduced 2.39%	5,932 $283,000
Q2 2019 Aug 12, 2019	BUY	$39.26 - $54.21 $238,583 - $329,434	6,077 New	6,077 $329,000

Others Institutions Holding CTLT

# of Institutions

514

Shares Held

149M

Call Options Held

575K

Put Options Held

2.03M

View Full List

About Catalent, Inc.

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

More about CTLT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of M&T Bank Corp, based on Form 13F filings with the SEC.

News

Stay updated on M&T Bank Corp with notifications on news.

Account